Volume 21, Issue 11 · 52 pages including cover
Move your pointer across the coverDrag across the cover to stir the light
New issue Volume 21 / Issue 11 / November 2026 / Asia Edition
Breakthroughs are arriving across Asia-Pacific, in endometriosis diagnostics, women’s cancer care, menopause and AI. The question is no longer whether the science works. It is whether the money, the evidence and the access follow.
Cover story by Ayesha Siddiqui · pages 17 to 30
Filter by desk, search the full text of every article, or read the contents the way it is printed.
The executives, analysts and editors on the record this month. Select any one to open their piece.
The licensing and M&A reported in this issue, and the women's health programmes behind the cover story.
The gap is one of allocation as much as science. Around 20 per cent of research funding across the ten conditions analysed is women-focused, and more than half of that sits in ovarian cancer and menopause. Women-focused work accounts for 16 per cent of scientific publications and fewer than 3 per cent of clinical trials across the conditions studied. Asia's women's health AI market, meanwhile, is forecast to grow from $889 million in 2025 to $5.7 billion by 2034.
All 52 pages exactly as they went to press, each one indexed. Use the arrow keys, or select a page to enlarge it.
